Company Filing History:
Years Active: 2014
Title: Lilli Yang: Innovator in Retroviral Research
Introduction
Lilli Yang is a prominent inventor based in Pasadena, CA. She has made significant contributions to the field of retroviral research, particularly in the development of innovative methods for gene delivery. Her work focuses on utilizing retrovirus pseudotyping to enhance therapeutic applications.
Latest Patents
Lilli Yang holds a patent for "Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein." This patent describes methods and compositions for delivering a polynucleotide encoding a gene of interest, typically an antigen, to dendritic cells. The virus envelope includes a DC-SIGN specific targeting molecule. These methods can be utilized to treat patients suffering from various conditions, including infections like HIV/AIDS and different types of cancers. She has 1 patent to her name.
Career Highlights
Lilli Yang is affiliated with the California Institute of Technology, where she conducts her research. Her work has garnered attention for its potential impact on therapeutic strategies in the medical field.
Collaborations
Lilli has collaborated with notable scientists, including Pin Wang and David Baltimore, enhancing the scope and depth of her research endeavors.
Conclusion
Lilli Yang's innovative work in retroviral research exemplifies the potential of scientific advancements in treating serious health conditions. Her contributions continue to inspire future research in gene therapy and related fields.